Starting July 12, 2024 the healthcare sector must comply with the new, stricter occupational exposure limits for formaldehyde, marking the end of the 5-year tra...
Addax Biosciences is excited to share that our acid-free glyoxal formulation has been used in a recent study, demonstrating superior performance in preserving n...
We are pleased to share another significant step in the entrepreneurial development of Addax Biosciences: Fintech Partners, investment sub-holding controlled by...
We are excited to share another remakable recent study on alternative protocols of tissue fixation that have the potential to revolutionize the interpretation o...
An open label, non-inferiority, multicentric trial proves that Glyoxal Acid-Free (GAF®) histological fixative is a suitable alternative to Formalin. The tri...
We are pleased to share the remarkable outcomes of a recent multi-institutional groundbreaking study: NON-TOXIC ACID-FREE GLYOXAL FIXATIVE FOR VETERINARY HIS...
We are pleased to announce that our GAF® formalin free fixative solution joined the World’s greenest hospital initiative. The fictional city of Grønnköping...
In September 2022 the CEO and founder of Addax Biosciences Professor Bussolati, closed the 34th European Congress of Pathology, with his keynote lecture, entit...
Addax Biosciences has been selected as semi-finalist among a group of top health start-ups with great investment potential in the 2021 EIT Health Catapult Semif...
We have added a new section on our website where you can find protocols on how to use GAF as substitute for formalin in immunohystochemistry. Immunohystochem...
To provide the best experiences, we use technologies such as cookies to store and / or access device information. Consent to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent may adversely affect some features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
L'archiviazione tecnica o l'accesso sono necessari per creare profili di utenti per inviare pubblicità, o per tracciare l'utente su un sito web o su diversi siti web per scopi di marketing simili.